{"organizations": [], "uuid": "56af74bd4df287f6dec0187d9170da3cea09ff96", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 19, "shares": 19, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s3.reutersmedia.net/resources/r/?m=02&d=20180403&t=2&i=1247628653&w=1200&r=LYNXNPEE3212M", "site_section": "http://feeds.reuters.com/reuters/topNews", "section_title": "Reuters: Top News", "url": "https://www.reuters.com/article/us-pfizer-divestiture-procter-gamble/pfizer-in-talks-with-pg-for-consumer-health-unit-sale-cnbc-idUSKCN1HA1UK", "country": "US", "domain_rank": 408, "title": "Pfizer in talks with P&G for consumer health unit sale: CNBC", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-03T17:51:00.000+03:00", "replies_count": 0, "uuid": "56af74bd4df287f6dec0187d9170da3cea09ff96"}, "author": "", "url": "https://www.reuters.com/article/us-pfizer-divestiture-procter-gamble/pfizer-in-talks-with-pg-for-consumer-health-unit-sale-cnbc-idUSKCN1HA1UK", "ord_in_thread": 0, "title": "Pfizer in talks with P&G for consumer health unit sale: CNBC", "locations": [], "entities": {"persons": [{"name": "reuters/andrew kelly  pfizer", "sentiment": "none"}, {"name": "sriraj kalluvila", "sentiment": "none"}], "locations": [{"name": "new york", "sentiment": "none"}, {"name": "u.s.", "sentiment": "none"}, {"name": "bengaluru", "sentiment": "none"}, {"name": "manhattan", "sentiment": "none"}], "organizations": [{"name": "p&g", "sentiment": "negative"}, {"name": "cnbc", "sentiment": "negative"}, {"name": "pfizer", "sentiment": "negative"}, {"name": "manas mishra", "sentiment": "none"}, {"name": "cnbc reuters staff", "sentiment": "none"}, {"name": "procter & gamble co p&g", "sentiment": "none"}, {"name": "glaxosmithkline", "sentiment": "none"}, {"name": "reckitt benckiser", "sentiment": "none"}, {"name": "johnson & johnson", "sentiment": "none"}, {"name": "pfizer inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "(Reuters) - Pfizer Inc is in talks with Procter & Gamble Co for a sale of the largest U.S. drugmakerâ€™s consumer health business, CNBC reported on Tuesday, citing sources.\nThe Pfizer logo is seen at their world headquarters in Manhattan, New York, U.S., August 1, 2016. REUTERS/Andrew Kelly The companies were far apart on a price for the business and Pfizer is considering other options, including a joint venture with other drugmakers, the report said.\nPfizer said it is evaluating potential strategic options for the unit and expects to make a decision in 2018.\nGlaxoSmithKline, Reckitt Benckiser and Johnson & Johnson have all exited from the bidding process, endangering an auction Pfizer hoped would bring in as much as $20 billion\nP&G said it declined to comment.\nReporting by Manas Mishra in Bengaluru; Editing by Sriraj Kalluvila\n ", "external_links": [], "published": "2018-04-03T17:51:00.000+03:00", "crawled": "2018-04-03T18:01:43.013+03:00", "highlightTitle": ""}